Optomed Oyj — Major Shareholding Notification 2021

Apr 30, 2021

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed Plc         Stock Exchange Release    30 April 2021 at 9.30, Helsinki

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding
change in holdings

Optomed Plc (“Optomed” or the “Company”) has received a notification in
accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act
(as amended, the “SMA”) from BI Asset Management Fondsmægler-selskab A/S
(“BIAM”). According to the notification, the total holdings in Optomed shares
and votes held by BIAM has increased to 5.69 % per cent of all of the registered
shares in Optomed on 28 April 2021.

The total number of the Company’s registered shares amounts to 14,003,144
shares. Each share entitles to one vote.

The total position of BIAM subject to the notification:

              % of        % of shares and voting rights         Total of
              shares and  through financial instruments (total  both in %
              voting      of B)                                 (A+B)
              rights
              (total
              of A)

Resulting 5.69 % - 5.69 %
situation on the
date on
which threshold
was crossed or
reached
Position of - - -
previous
notification
(if applicable)

Notified details of the resulting situation on the date on which the threshold
was crossed or reached:

A: Shares and voting rights

Class/type of Number % of shares and voting rights
sharesISIN of
code shares
and
voting
rights
Direct Indirect Direct Indirect
(SMA 9:5) (SMA 9:6 (SMA 9:5) (SMA 9:6 ja 9:7)
ja 9:7)
FI4000410881 796,773 - 5.69 % -
SUBTOTAL A 796,773 5.69 %

Information in relation to the person subject to the notification obligation as
contained in the notification

The complete chain of controlled undertakings through which the shares, voting
rights and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity:

Name % of shares % of shares and voting rights Total
and voting through financial instruments of
rights both
BI Asset Management - - -
Fondsmægler-selskab
A/S
Kapitalforeningen 2.51 % - 2.51 %
Unite II,
Europæiske Small Cap
Aktier KL
Investeringsforeningen 3.18 % - 3.18 %
BankInvest, Europa
Small Cap
Aktier KL

Further enquiries

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com, +358(0)50 562
4077.

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld screening devices fundus
cameras with software and artificial intelligence with the aim to transform the
diagnostic process of blinding eye-diseases such as rapidly increasing diabetic
retinopathy. In its business Optomed focuses on eye-screening devices and
software solutions related R&D in Finland and sales through different channels
in over 60 countries. The company has an extensive portfolio of 56 international
patents protecting the technology.